|
| | Tecovirimat Basic information |
| Product Name: | Tecovirimat | | Synonyms: | tecovirimat;rel-N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)benzamide;Tecovirimat USP/EP/BP | | CAS: | 816458-31-8 | | MF: | C19H15F3N2O3 | | MW: | 376.332 | | EINECS: | | | Product Categories: | API | | Mol File: | 816458-31-8.mol |  |
| | Tecovirimat Chemical Properties |
| Melting point | 194-195 ºC | | density | 1.53 | | storage temp. | -20°C Freezer | | solubility | Dichloromethane (Slightly), DMSO Slightly() | | form | Solid | | color | White to Off-White |
| | Tecovirimat Usage And Synthesis |
| Uses | Tecovirimat is an orally bioavailable antipoxvirus compound inhibits extracellular virus formation and protects mice from lethal orthopoxvirus, including vaccinia, monkeypox, camelpox, cowpox, ectromelia (mousepox), and variola viruses. |
| | Tecovirimat Preparation Products And Raw materials |
|
